A carregar...
Melanoma brain metastases: review of histopathological features and immune-molecular aspects
Patients with melanoma brain metastases (MBM) have a dismal prognosis, but the unprecedented advances in systemic therapy alone or in combination with local therapy have now extended the 1-year overall survival rate from 20–25% to nearing 80–85%, mainly in asymptomatic patients. The histopathologica...
Na minha lista:
| Publicado no: | Melanoma Manag |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7426753/ https://ncbi.nlm.nih.gov/pubmed/32821376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt-2019-0021 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|